Day-to-day management of the Cancer Center is nearly synonymous with day-to-day management of the City of Hope National Medical Center &Beckman Research Institute. Administration supports Cancer Center research by providing business administration functions (e.g., budgeting and accounting for shared resources, CCSG budgets, and other cancer research-related budgets;preparing productivity and other analyses);planning functions (e.g., strategic, facilities, recruitment, and capital);information systems functions (e.g., databases for CCSG-required data);general administrative support (e.g., committee and meeting management, seminar arrangements, data entry, word processing);and external relations (e.g., professional organizations, NCI staff, other cancer centers, and other academic institutions). Leading the effort to continue the automation of key infrastructure systems, center administration has played a pivotal role in enhancing the research environment. This includes the implementation of a new process management system for automation of both the scientific review and the human subjects review processes for clinical research protocols, the introduction of a LIMS system to many of the shared resources, and an ongoing project to install a common """"""""back-end"""""""" for all shared resource data collection and billing. In addition, the clinical research support structure has been greatly enhanced with the creation of centralized support systems, an updated Data and Safety Monitoring Plan and the creation of an independent clinical research auditing function. This request is for $204,294 for salary and benefits of 2.4 FTEs to support administrative functions (excluding clinical research support systems, which are in the Data and Safety Monitoring budget) and $22,894 for the Cancer Center's Seminar Series. This represents 8.5% of the total cost of administration.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA033572-27
Application #
8182270
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-12-01
Budget End
2010-11-30
Support Year
27
Fiscal Year
2010
Total Cost
$315,383
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Salgia, Ravi; Kulkarni, Prakash; Gill, Prakash S (2018) EphB4: A promising target for upper aerodigestive malignancies. Biochim Biophys Acta Rev Cancer 1869:128-137
Choi, Audrey H; O'Leary, Michael P; Lu, Jianming et al. (2018) Endogenous Akt Activity Promotes Virus Entry and Predicts Efficacy of Novel Chimeric Orthopoxvirus in Triple-Negative Breast Cancer. Mol Ther Oncolytics 9:22-29
Kumar, B; Garcia, M; Weng, L et al. (2018) Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia 32:575-587
Zhou, Jiehua; Lazar, Daniel; Li, Haitang et al. (2018) Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1. Theranostics 8:1575-1590
Ding, Yuan Chun; Adamson, Aaron W; Steele, Linda et al. (2018) Discovery of mutations in homologous recombination genes in African-American women with breast cancer. Fam Cancer 17:187-195
Kurata, Jessica S; Lin, Ren-Jang (2018) MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs. RNA 24:966-981
Hardwick, Nicola R; Frankel, Paul; Ruel, Christopher et al. (2018) p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy. Clin Cancer Res 24:1315-1325
Dietze, Eric C; Chavez, Tanya A; Seewaldt, Victoria L (2018) Obesity and Triple-Negative Breast Cancer: Disparities, Controversies, and Biology. Am J Pathol 188:280-290
Kingsmore, Kathryn M; Vaccari, Andrea; Abler, Daniel et al. (2018) MRI analysis to map interstitial flow in the brain tumor microenvironment. APL Bioeng 2:
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096

Showing the most recent 10 out of 1396 publications